DIVALPROEX SODIUM

DIVALPROEX SODIUM was reported 46740 times

DIVALPROEX SODIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NEURAL TUBE DEFECT 326 0.4484
1 LIFE EXPECTANCY SHORTENED 196 0.3457
2 TOTAL LUNG CAPACITY INCREASED 89 0.3272
3 CONGENITAL CARDIOVASCULAR ANOMALY 188 0.2241
4 SPINA BIFIDA 430 0.2062
5 NEOVASCULARISATION 50 0.1901
6 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 89 0.1702
7 SCHIZOAFFECTIVE DISORDER 251 0.1406
8 PHYSICAL DISABILITY 544 0.1229
9 LOSS OF EMPLOYMENT 345 0.1141
10 SINUS RHYTHM 43 0.0986
11 MEDICATION RESIDUE 209 0.0810
12 MULTIPLE CONGENITAL ABNORMALITIES 112 0.0778
13 CONGENITAL MUSCULOSKELETAL ANOMALY 34 0.0771
14 ATONIC SEIZURES 66 0.0768
15 SOCIAL PROBLEM 312 0.0753
16 FOETAL ANTICONVULSANT SYNDROME 83 0.0700
17 ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC 51 0.0677
18 ANTICONVULSANT DRUG LEVEL DECREASED 94 0.0665
19 HYPERAMMONAEMIA 328 0.0655
20 GRANULOCYTOPENIA 371 0.0651
21 AMMONIA INCREASED 325 0.0636
22 ANTICONVULSANT DRUG LEVEL INCREASED 100 0.0619
23 DIABETIC COMA 170 0.0606
24 DEFORMITY 563 0.0602
25 HYPOMANIA 218 0.0592
26 DIABETES MELLITUS NON-INSULIN-DEPENDENT 82 0.0564
27 MOTOR DEVELOPMENTAL DELAY 32 0.0554
28 AUTISM 55 0.0541
29 TENSION 327 0.0536
30 BIPOLAR I DISORDER 116 0.0528
31 HYPERAMMONAEMIC ENCEPHALOPATHY 88 0.0506
32 COGWHEEL RIGIDITY 52 0.0495
33 SEIZURE CLUSTER 41 0.0495
34 BIPOLAR DISORDER 527 0.0484
35 COMPLEX PARTIAL SEIZURES 50 0.0450
36 COMPULSIVE SEXUAL BEHAVIOUR 35 0.0432
37 CONGENITAL ANOMALY 326 0.0421
38 MANIA 671 0.0407
39 DRUG LEVEL FLUCTUATING 36 0.0405
40 CEREBELLAR ATROPHY 35 0.0397
41 DRUG WITHDRAWAL CONVULSIONS 68 0.0382
42 PETIT MAL EPILEPSY 192 0.0376
43 MULTIPLE INJURIES 233 0.0370
44 INTELLECTUAL DISABILITY 56 0.0369
45 DIABETIC NEUROPATHY 182 0.0367
46 MYOCLONIC EPILEPSY 55 0.0362
47 TYPE 1 DIABETES MELLITUS 216 0.0358
48 SOLILOQUY 30 0.0347
49 GLYCOSURIA 45 0.0333
50 PSYCHIATRIC DECOMPENSATION 65 0.0332
51 SCHIZOPHRENIA 393 0.0323
52 OBESITY 505 0.0317
53 ANTIPSYCHOTIC DRUG LEVEL INCREASED 89 0.0316
54 SUBSTANCE USE 48 0.0307
55 JAUNDICE CHOLESTATIC 106 0.0300
56 FOCAL DYSCOGNITIVE SEIZURES 34 0.0299
57 HEART DISEASE CONGENITAL 105 0.0297
58 DYSMORPHISM 68 0.0288
59 DROOLING 197 0.0285
60 COMPULSIVE SHOPPING 57 0.0277
61 GAMBLING DISORDER 74 0.0274
62 CONVULSION 1562 0.0273
63 HEAD TITUBATION 37 0.0269
64 METABOLIC SYNDROME 44 0.0268
65 DRUG LEVEL DECREASED 272 0.0267
66 DIABETIC COMPLICATION 68 0.0267
67 FEELING GUILTY 35 0.0265
68 DRUG LEVEL INCREASED 436 0.0263
69 RHINITIS ALLERGIC 117 0.0263
70 HALLUCINATIONS, MIXED 109 0.0259
71 TYPE 2 DIABETES MELLITUS 869 0.0258
72 ANHEDONIA 671 0.0255
73 HOMICIDAL IDEATION 102 0.0251
74 PSYCHOTIC DISORDER 738 0.0250
75 CEREBRAL ATROPHY 98 0.0246
76 NEUROLEPTIC MALIGNANT SYNDROME 288 0.0243
77 METABOLIC DISORDER 140 0.0241
78 AURA 44 0.0236
79 SEIZURE 2704 0.0234
80 GENERALISED TONIC-CLONIC SEIZURE 368 0.0222
81 SEDATION COMPLICATION 56 0.0219
82 LANGUAGE DISORDER 47 0.0217
83 PRIAPISM 75 0.0217
84 HOSTILITY 55 0.0216
85 IMPULSIVE BEHAVIOUR 81 0.0216
86 STARING 52 0.0215
87 SEDATION 561 0.0214
88 PARKINSONISM 206 0.0211
89 BRAIN OPERATION 48 0.0210
90 PARTIAL SEIZURES 110 0.0210
91 CONVERSION DISORDER 40 0.0206
92 HALLUCINATION, AUDITORY 327 0.0206
93 BEHAVIOUR DISORDER 111 0.0205
94 WRONG PATIENT RECEIVED PRODUCT 60 0.0205
95 GRAND MAL CONVULSION 189 0.0204
96 BLOOD PROLACTIN INCREASED 96 0.0203
97 INAPPROPRIATE AFFECT 32 0.0202
98 LOGORRHOEA 71 0.0201
99 PHYSICAL ASSAULT 42 0.0201
100 AGGRESSION 1005 0.0201
101 SARCOIDOSIS 94 0.0198
102 HYPERLIPIDAEMIA 235 0.0196
103 DELUSION 305 0.0196
104 TACHYPHRENIA 68 0.0196
105 NASAL POLYPS 95 0.0193
106 ECONOMIC PROBLEM 291 0.0192
107 ABNORMAL BEHAVIOUR 759 0.0191
108 PARANOIA 328 0.0190
109 SPEECH DISORDER DEVELOPMENTAL 54 0.0188
110 CLEFT PALATE 36 0.0186
111 OBSESSIVE-COMPULSIVE DISORDER 149 0.0185
112 BLOOD TRIGLYCERIDES INCREASED 325 0.0184
113 HYPERSEXUALITY 33 0.0180
114 ELECTROENCEPHALOGRAM ABNORMAL 57 0.0180
115 PERSONALITY DISORDER 47 0.0179
116 ENURESIS 72 0.0178
117 HYPERNATRAEMIA 88 0.0176
118 DISTURBANCE IN SOCIAL BEHAVIOUR 41 0.0174
119 PARADOXICAL DRUG REACTION 64 0.0174
120 DIABETES MELLITUS 1312 0.0172
121 CARDIAC MURMUR 148 0.0171
122 DRUG LEVEL BELOW THERAPEUTIC 94 0.0170
123 METABOLIC ENCEPHALOPATHY 51 0.0170
124 PSYCHOMOTOR SKILLS IMPAIRED 43 0.0164
125 IMPAIRED SELF-CARE 34 0.0164
126 EXTRAPYRAMIDAL DISORDER 407 0.0164
127 GLUCOSE TOLERANCE IMPAIRED 95 0.0160
128 DIABETES MELLITUS INADEQUATE CONTROL 284 0.0160
129 DIABETIC NEPHROPATHY 35 0.0159
130 DEVELOPMENTAL DELAY 143 0.0158
131 CATATONIA 83 0.0158
132 MULTIPLE-DRUG RESISTANCE 49 0.0158
133 ANAEMIA MACROCYTIC 33 0.0154
134 POLYDIPSIA 61 0.0154
135 THERAPEUTIC AGENT TOXICITY 51 0.0153
136 AFFECTIVE DISORDER 120 0.0152
137 ACTIVITIES OF DAILY LIVING IMPAIRED 301 0.0152
138 TARDIVE DYSKINESIA 427 0.0151
139 POST-TRAUMATIC STRESS DISORDER 98 0.0146
140 PARKINSON'S DISEASE 37 0.0145
141 PSYCHOTIC SYMPTOM 30 0.0145
142 STATUS EPILEPTICUS 163 0.0144
143 HYPOSPADIAS 30 0.0144
144 PANCREATITIS CHRONIC 34 0.0143
145 BLOOD CHOLESTEROL ABNORMAL 66 0.0143
146 WOUND COMPLICATION 49 0.0143
147 ATAXIA 169 0.0142
148 HYPERLACTACIDAEMIA 38 0.0142
149 STUPOR 45 0.0140
150 HYPERPHAGIA 55 0.0138
151 BRONCHIECTASIS 91 0.0135
152 SCREAMING 86 0.0135
153 DIABETIC KETOACIDOSIS 324 0.0135
154 COMMUNICATION DISORDER 51 0.0133
155 FACIAL BONES FRACTURE 48 0.0133
156 HYPERTRIGLYCERIDAEMIA 78 0.0133
157 IMPAIRED WORK ABILITY 281 0.0131
158 SALIVARY HYPERSECRETION 131 0.0131
159 SUICIDAL BEHAVIOUR 54 0.0130
160 SELF-INJURIOUS IDEATION 54 0.0129
161 ANGER 435 0.0129
162 MAJOR DEPRESSION 94 0.0129
163 THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION 53 0.0127
164 AUTISM SPECTRUM DISORDER 70 0.0127
165 INGROWING NAIL 30 0.0127
166 HYPERSOMNIA 364 0.0127
167 CYTOLYTIC HEPATITIS 42 0.0126
168 AGITATION 918 0.0125
169 RESPIRATORY DEPRESSION 153 0.0125
170 SELF INJURIOUS BEHAVIOUR 38 0.0124
171 DIABETIC RETINOPATHY 42 0.0124
172 PSYCHOMOTOR HYPERACTIVITY 205 0.0123
173 HYPERPROLACTINAEMIA 80 0.0123
174 COORDINATION ABNORMAL 168 0.0120
175 POSTURE ABNORMAL 39 0.0120
176 PANCREATITIS 630 0.0119
177 MONOCYTE COUNT INCREASED 43 0.0118
178 MEDICATION RESIDUE PRESENT 56 0.0117
179 ALCOHOL USE 43 0.0116
180 GYNAECOMASTIA 360 0.0116
181 MENTAL DISORDER 506 0.0116
182 MENTAL STATUS CHANGES 322 0.0116
183 SOCIAL AVOIDANT BEHAVIOUR 67 0.0116
184 AKATHISIA 158 0.0116
185 THERMAL BURN 81 0.0114
186 COMA 543 0.0114
187 DRUG LEVEL ABOVE THERAPEUTIC 52 0.0113
188 THINKING ABNORMAL 211 0.0113
189 TALIPES 35 0.0113
190 NEGATIVE THOUGHTS 33 0.0113
191 ALCOHOL ABUSE 30 0.0112
192 TREMOR 1855 0.0112
193 EYE MOVEMENT DISORDER 76 0.0111
194 INCREASED APPETITE 212 0.0111
195 PRESCRIBED OVERDOSE 212 0.0109
196 SLEEP APNOEA SYNDROME 209 0.0109
197 PRODUCT RESIDUE PRESENT 59 0.0109
198 ENCEPHALOPATHY 268 0.0109
199 SUICIDAL IDEATION 986 0.0108
200 HYPOTHERMIA 109 0.0108
201 COGNITIVE DISORDER 499 0.0107
202 HYPERGLYCAEMIA 384 0.0105
203 FAECAL INCONTINENCE 50 0.0104
204 DYSKINESIA 422 0.0104
205 PNEUMONIA ASPIRATION 259 0.0104
206 LUNG NEOPLASM 44 0.0103
207 SUICIDE ATTEMPT 624 0.0103
208 ALCOHOLISM 44 0.0103
209 DYSARTHRIA 386 0.0102
210 OVERWEIGHT 55 0.0102
211 HALLUCINATION, VISUAL 216 0.0102
212 FEELING DRUNK 76 0.0102
213 INCONTINENCE 108 0.0102
214 INCOHERENT 66 0.0102
215 MENTAL IMPAIRMENT 246 0.0101
216 QUALITY OF LIFE DECREASED 136 0.0101
217 SEROTONIN SYNDROME 193 0.0100
218 DYSPHEMIA 44 0.0100
219 LETHARGY 577 0.0100
220 BLOOD CHOLESTEROL INCREASED 465 0.0100
221 GALACTORRHOEA 64 0.0100
222 LIVE BIRTH 83 0.0099
223 CRANIOCEREBRAL INJURY 30 0.0099
224 SOMNAMBULISM 65 0.0099
225 FOETAL EXPOSURE DURING PREGNANCY 799 0.0098
226 INJURY 688 0.0098
227 WEIGHT INCREASED 2183 0.0097
228 TIC 53 0.0097
229 EPILEPSY 297 0.0097
230 MULTIPLE DRUG OVERDOSE 48 0.0097
231 REFUSAL OF TREATMENT BY PATIENT 63 0.0096
232 ELECTROCARDIOGRAM QT PROLONGED 346 0.0096
233 HIGH DENSITY LIPOPROTEIN DECREASED 32 0.0096
234 DIFFICULTY IN WALKING 33 0.0096
235 SOMNOLENCE 1929 0.0096
236 IRRITABILITY 576 0.0096
237 POLYURIA 78 0.0095
238 PANCREATITIS ACUTE 210 0.0093
239 DISSOCIATION 71 0.0093
240 DRUG TOXICITY 126 0.0092
241 TREATMENT NONCOMPLIANCE 505 0.0092
242 URINARY INCONTINENCE 269 0.0091
243 MOOD SWINGS 288 0.0090
244 MUSCLE RIGIDITY 108 0.0090
245 ANXIETY DISORDER 30 0.0090
246 PRE-EXISTING CONDITION IMPROVED 56 0.0090
247 CHOLELITHIASIS 294 0.0090
248 DRUG EXPOSURE DURING PREGNANCY 304 0.0089
249 MOTOR DYSFUNCTION 91 0.0089
250 DEPRESSED LEVEL OF CONSCIOUSNESS 352 0.0089
251 FLANK PAIN 83 0.0088
252 DRUG INTERACTION 1388 0.0087
253 AFFECT LABILITY 84 0.0087
254 PERSONALITY CHANGE 81 0.0087
255 HEPATIC STEATOSIS 162 0.0087
256 HALLUCINATION 649 0.0086
257 SPEECH DISORDER 451 0.0086
258 HEAD INJURY 272 0.0086
259 MOOD ALTERED 233 0.0085
260 PRODUCT ADMINISTRATION INTERRUPTED 67 0.0085
261 TRISMUS 44 0.0085
262 DYSTONIA 165 0.0085
263 ASPIRATION 93 0.0085
264 FAECALOMA 46 0.0084
265 DELIRIUM 291 0.0084
266 BRADYPHRENIA 54 0.0083
267 HYPERTHERMIA 63 0.0082
268 BRUXISM 44 0.0082
269 KETOACIDOSIS 61 0.0081
270 MYOCARDITIS 93 0.0081
271 HYDROCEPHALUS 44 0.0081
272 PATENT DUCTUS ARTERIOSUS 32 0.0081
273 DISORIENTATION 319 0.0080
274 ABNORMAL WEIGHT GAIN 99 0.0080
275 MIOSIS 64 0.0080
276 SNORING 30 0.0079
277 TRICUSPID VALVE INCOMPETENCE 63 0.0079
278 EUPHORIC MOOD 81 0.0079
279 DYSLIPIDAEMIA 40 0.0079
280 EMOTIONAL DISORDER 239 0.0077
281 EMOTIONAL DISTRESS 937 0.0077
282 DISTURBANCE IN ATTENTION 417 0.0077
283 NYSTAGMUS 41 0.0077
284 NEUTROPHIL COUNT INCREASED 79 0.0077
285 CONCUSSION 59 0.0076
286 FOOD CRAVING 40 0.0076
287 AMNESIA 494 0.0076
288 RESTLESSNESS 277 0.0076
289 STEVENS-JOHNSON SYNDROME 168 0.0075
290 PSYCHIATRIC SYMPTOM 55 0.0074
291 BRAIN INJURY 74 0.0074
292 ANURIA 63 0.0073
293 HYPOTONIA 73 0.0073
294 ATRIAL SEPTAL DEFECT 60 0.0072
295 SEXUAL DYSFUNCTION 84 0.0072
296 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 73 0.0071
297 RESTLESS LEGS SYNDROME 127 0.0070
298 CONFUSIONAL STATE 1122 0.0069
299 HYPERCHOLESTEROLAEMIA 67 0.0069
300 PANIC REACTION 50 0.0069
301 DEPRESSION 1568 0.0069
302 CRYING 250 0.0069
303 MYOCLONUS 82 0.0069
304 FEELING OF DESPAIR 32 0.0069
305 HAEMATOCRIT DECREASED 136 0.0069
306 EATING DISORDER 146 0.0068
307 HEPATOTOXICITY 152 0.0068
308 DECREASED INTEREST 40 0.0068
309 SCOLIOSIS 42 0.0068
310 ORTHOSTATIC HYPOTENSION 118 0.0068
311 POISONING DELIBERATE 64 0.0067
312 DEMENTIA 188 0.0067
313 CHOKING 130 0.0067
314 POOR QUALITY SLEEP 143 0.0066
315 VISUAL DISTURBANCE 38 0.0066
316 SINUS TACHYCARDIA 94 0.0066
317 AGRANULOCYTOSIS 123 0.0066
318 PANIC ATTACK 240 0.0066
319 PRODUCT SUBSTITUTION ISSUE 379 0.0066
320 DRUG SCREEN POSITIVE 52 0.0066
321 NONSPECIFIC REACTION 36 0.0066
322 PRODUCT PREPARATION ISSUE 43 0.0065
323 BALANCE DISORDER 564 0.0065
324 UNRESPONSIVE TO STIMULI 167 0.0065
325 VENTRICULAR SEPTAL DEFECT 37 0.0065
326 HYPERTONIA 37 0.0065
327 BRADYKINESIA 38 0.0064
328 INTENTIONAL SELF-INJURY 130 0.0064
329 INITIAL INSOMNIA 66 0.0064
330 MATERNAL DRUGS AFFECTING FOETUS 49 0.0064
331 NIGHTMARE 221 0.0064
332 MUSCLE TWITCHING 147 0.0064
333 APATHY 93 0.0064
334 BUNDLE BRANCH BLOCK RIGHT 29 0.0063
335 SLUGGISHNESS 64 0.0063
336 LACERATION 59 0.0063
337 ENERGY INCREASED 37 0.0063
338 BLOOD LACTIC ACID INCREASED 33 0.0063
339 LEUKOPENIA 312 0.0062
340 MIGRAINE 591 0.0062
341 MUSCLE DISORDER 50 0.0062
342 ROAD TRAFFIC ACCIDENT 258 0.0062
343 APHASIA 186 0.0062
344 DRUG DISPENSING ERROR 94 0.0061
345 BLOOD TESTOSTERONE DECREASED 42 0.0061
346 ANOREXIA 79 0.0061
347 DIPLOPIA 159 0.0061
348 ANAL INCONTINENCE 55 0.0061
349 CEREBRAL DISORDER 45 0.0061
350 DYSGRAPHIA 40 0.0061
351 ANXIETY 1723 0.0060
352 MIDDLE INSOMNIA 113 0.0060
353 ERECTILE DYSFUNCTION 155 0.0060
354 BLOOD CREATINE PHOSPHOKINASE INCREASED 173 0.0060
355 ATELECTASIS 58 0.0060
356 HORMONE LEVEL ABNORMAL 29 0.0059
357 TONGUE DISORDER 43 0.0059
358 EOSINOPHILIA 104 0.0059
359 THIRST 106 0.0059
360 TOXIC ENCEPHALOPATHY 30 0.0059
361 INSOMNIA 1568 0.0059
362 ABASIA 145 0.0059
363 ABNORMAL DREAMS 162 0.0059
364 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 305 0.0058
365 LEARNING DISABILITY 31 0.0058
366 BLOOD SODIUM DECREASED 109 0.0058
367 WALKING AID USER 38 0.0058
368 HUNGER 80 0.0057
369 LIPASE INCREASED 44 0.0057
370 ELECTROCARDIOGRAM ABNORMAL 45 0.0057
371 FOOT FRACTURE 108 0.0057
372 SINUS BRADYCARDIA 55 0.0057
373 RHABDOMYOLYSIS 237 0.0057
374 OSTEOPENIA 86 0.0057
375 DISABILITY 112 0.0057
376 BRAIN OEDEMA 71 0.0056
377 UNEVALUABLE EVENT 422 0.0056
378 BLEPHAROSPASM 35 0.0056
379 SUBSTANCE ABUSE 45 0.0055
380 INTENTIONAL OVERDOSE 354 0.0055
381 FEAR 147 0.0055
382 IMPAIRED DRIVING ABILITY 62 0.0054
383 LEUKOCYTOSIS 98 0.0054
384 BEDRIDDEN 71 0.0054
385 FALL 1792 0.0054
386 HYPOPHAGIA 136 0.0053
387 APPETITE DISORDER 35 0.0053
388 HYPONATRAEMIA 297 0.0053
389 SPINAL OSTEOARTHRITIS 46 0.0052
390 MEMORY IMPAIRMENT 715 0.0052
391 HYPOTHYROIDISM 166 0.0052
392 NERVOUSNESS 271 0.0052
393 MOVEMENT DISORDER 166 0.0052
394 DENTAL CARIES 57 0.0051
395 BLOOD BILIRUBIN INCREASED 139 0.0051
396 NERVOUS SYSTEM DISORDER 160 0.0051
397 RESPIRATORY DISTRESS 141 0.0051
398 FULL BLOOD COUNT ABNORMAL 54 0.0051
399 DECREASED ACTIVITY 55 0.0051
400 HYPOGLYCAEMIA 247 0.0051
401 CHOLECYSTITIS CHRONIC 34 0.0051
402 RENAL FAILURE CHRONIC 39 0.0051
403 DYSSTASIA 148 0.0051
404 BACK INJURY 55 0.0051
405 DECUBITUS ULCER 41 0.0050
406 HYPERVENTILATION 29 0.0050
407 INTERVERTEBRAL DISC DEGENERATION 46 0.0050
408 MITRAL VALVE INCOMPETENCE 56 0.0049
409 OBSTRUCTIVE AIRWAYS DISORDER 55 0.0049
410 VITAMIN D DECREASED 42 0.0049
411 DYSPHAGIA 465 0.0049
412 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 43 0.0049
413 BLADDER DISORDER 48 0.0048
414 ARTERIOSCLEROSIS CORONARY ARTERY 32 0.0048
415 GAIT DISTURBANCE 919 0.0048
416 LOW DENSITY LIPOPROTEIN INCREASED 37 0.0048
417 SLEEP DISORDER 336 0.0048
418 HEPATIC ENZYME INCREASED 324 0.0047
419 DEPRESSED MOOD 251 0.0047
420 RETCHING 101 0.0047
421 CARDIOMYOPATHY 70 0.0047
422 STAPHYLOCOCCAL INFECTION 156 0.0047
423 DRUG ABUSER 29 0.0047
424 CARDIOMEGALY 58 0.0047
425 HEPATIC ENCEPHALOPATHY 44 0.0047
426 VISUAL FIELD DEFECT 34 0.0047
427 ACUTE HEPATIC FAILURE 64 0.0047
428 LIVER FUNCTION TEST ABNORMAL 136 0.0047
429 BLOOD ALBUMIN DECREASED 37 0.0047
430 ACUTE RESPIRATORY DISTRESS SYNDROME 82 0.0046
431 LOSS OF CONSCIOUSNESS 591 0.0046
432 SKIN LACERATION 50 0.0046
433 SENSORY LOSS 37 0.0046
434 PHOTOPHOBIA 86 0.0046
435 GASTROOESOPHAGEAL REFLUX DISEASE 367 0.0046
436 MALNUTRITION 51 0.0046
437 LIGAMENT SPRAIN 45 0.0045
438 SENSORY DISTURBANCE 73 0.0045
439 SUDDEN DEATH 48 0.0045
440 TOXICITY TO VARIOUS AGENTS 762 0.0045
441 VITAMIN D DEFICIENCY 44 0.0045
442 ANKLE FRACTURE 69 0.0045
443 JOINT INJURY 94 0.0044
444 WEIGHT FLUCTUATION 46 0.0044
445 ALTERED STATE OF CONSCIOUSNESS 95 0.0044
446 MICTURITION URGENCY 50 0.0044
447 HEPATOMEGALY 43 0.0044
448 OEDEMA PERIPHERAL 533 0.0044
449 NICOTINE DEPENDENCE 34 0.0044
450 OSTEOPOROSIS 179 0.0043
451 WRIST FRACTURE 52 0.0043
452 HEPATITIS C 52 0.0043
453 ALOPECIA 844 0.0043
454 CHOLECYSTECTOMY 49 0.0043
455 RENAL FAILURE ACUTE 182 0.0043
456 RIB FRACTURE 88 0.0043
457 APNOEA 33 0.0042
458 TOOTH ABSCESS 43 0.0042
459 TOXIC EPIDERMAL NECROLYSIS 64 0.0042
460 THROMBOCYTOPENIA 471 0.0042
461 INTERVERTEBRAL DISC PROTRUSION 92 0.0042
462 TROPONIN INCREASED 32 0.0042
463 FIBROMYALGIA 102 0.0042
464 FEELING ABNORMAL 1005 0.0042
465 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 30 0.0042
466 CELLULITIS 211 0.0042
467 WRONG TECHNIQUE IN DRUG USAGE PROCESS 152 0.0042
468 HYPOXIA 147 0.0042
469 FORMICATION 29 0.0042
470 FURUNCLE 33 0.0042
471 HYPERTENSION 879 0.0041
472 NEUTROPHIL COUNT DECREASED 168 0.0041
473 ACUTE RESPIRATORY FAILURE 79 0.0041
474 HAND FRACTURE 29 0.0041
475 GALLBLADDER DISORDER 73 0.0041
476 EOSINOPHIL COUNT INCREASED 34 0.0041
477 SUPRAVENTRICULAR TACHYCARDIA 39 0.0041
478 WHITE BLOOD CELL COUNT INCREASED 156 0.0041
479 METABOLIC ACIDOSIS 130 0.0041
480 EMPHYSEMA 41 0.0041
481 AMENORRHOEA 71 0.0040
482 NERVE INJURY 45 0.0040
483 DEAFNESS 104 0.0040
484 WITHDRAWAL SYNDROME 167 0.0040
485 RENAL TUBULAR NECROSIS 39 0.0040
486 INTENTIONAL DRUG MISUSE 83 0.0040
487 THERAPY CHANGE 39 0.0040
488 WEIGHT DECREASED 1106 0.0040
489 THYROID DISORDER 61 0.0040
490 TACHYCARDIA 350 0.0039
491 CHRONIC KIDNEY DISEASE 299 0.0039
492 GASTROENTERITIS VIRAL 71 0.0039
493 POLLAKIURIA 162 0.0039
494 GASTRITIS 102 0.0039
495 IRRITABLE BOWEL SYNDROME 83 0.0039
496 WOUND 108 0.0039
497 PALLOR 105 0.0039
498 EAR PAIN 75 0.0039
499 TACHYPNOEA 52 0.0038
500 TRANSIENT ISCHAEMIC ATTACK 129 0.0038
501 OVERDOSE 824 0.0038
502 IMPAIRED GASTRIC EMPTYING 52 0.0038
503 MUSCLE STRAIN 33 0.0038
504 HYSTERECTOMY 33 0.0038
505 TOOTH FRACTURE 42 0.0038
506 HEPATOCELLULAR INJURY 54 0.0038
507 TINNITUS 173 0.0038
508 BLOOD UREA INCREASED 63 0.0038
509 EAR INFECTION 100 0.0038
510 HAEMORRHOIDS 73 0.0037
511 NEUTROPENIA 506 0.0037
512 HEMIPARESIS 63 0.0037
513 GENERALISED OEDEMA 46 0.0037
514 CARPAL TUNNEL SYNDROME 52 0.0037
515 PHARYNGITIS 46 0.0037
516 DRUG PRESCRIBING ERROR 71 0.0037
517 BLOOD THYROID STIMULATING HORMONE INCREASED 34 0.0037
518 RENAL DISORDER 172 0.0037
519 IRON DEFICIENCY ANAEMIA 34 0.0037
520 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 202 0.0037
521 VISION BLURRED 504 0.0037
522 DYSURIA 135 0.0037
523 MYDRIASIS 47 0.0037
524 DRUG DOSE OMISSION 605 0.0037
525 PHARMACEUTICAL PRODUCT COMPLAINT 95 0.0037
526 OEDEMA 198 0.0036
527 LIMB INJURY 99 0.0036
528 HIATUS HERNIA 47 0.0036
529 FEEDING DISORDER 73 0.0036
530 LOWER LIMB FRACTURE 69 0.0036
531 NEUROPATHY PERIPHERAL 340 0.0036
532 DEHYDRATION 476 0.0036
533 NEPHROPATHY TOXIC 40 0.0036
534 CONTUSION 342 0.0035
535 ASPHYXIA 29 0.0035
536 DRUG EFFECT DECREASED 191 0.0035
537 HOSPICE CARE 35 0.0035
538 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 91 0.0035
539 VOMITING 1661 0.0035
540 ACCIDENT 42 0.0035
541 HYPOKINESIA 51 0.0035
542 PURPURA 31 0.0035
543 OVARIAN CYST 35 0.0035
544 GASTROENTERITIS 51 0.0035
545 RESPIRATORY RATE INCREASED 31 0.0035
546 RENAL PAIN 37 0.0035
547 PNEUMONIA 1127 0.0035
548 FACIAL PAIN 31 0.0035
549 INTERNATIONAL NORMALISED RATIO INCREASED 99 0.0035
550 NOCTURIA 42 0.0035
551 MUSCULAR WEAKNESS 393 0.0035
552 LOSS OF LIBIDO 31 0.0034
553 SCAR 59 0.0034
554 PLATELET COUNT DECREASED 367 0.0034
555 UPPER RESPIRATORY TRACT INFECTION 159 0.0034
556 WHEEZING 204 0.0034
557 HAIR TEXTURE ABNORMAL 46 0.0034
558 URINARY TRACT INFECTION 586 0.0034
559 MYOCARDIAL ISCHAEMIA 39 0.0034
560 CONDITION AGGRAVATED 1041 0.0034
561 DRY MOUTH 277 0.0034
562 UPPER LIMB FRACTURE 68 0.0034
563 SMALL INTESTINAL OBSTRUCTION 42 0.0034
564 GAIT INABILITY 114 0.0034
565 END STAGE RENAL DISEASE 62 0.0034
566 ASPARTATE AMINOTRANSFERASE INCREASED 179 0.0034
567 ELECTROLYTE IMBALANCE 39 0.0034
568 OXYGEN SATURATION DECREASED 188 0.0033
569 THERAPEUTIC RESPONSE UNEXPECTED 150 0.0033
570 CHEST PAIN 619 0.0033
571 HOSPITALISATION 512 0.0033
572 ILL-DEFINED DISORDER 202 0.0033
573 RED BLOOD CELL COUNT DECREASED 95 0.0033
574 JOINT DISLOCATION 35 0.0033
575 HEPATIC CYTOLYSIS 42 0.0033
576 MASS 46 0.0033
577 BODY TEMPERATURE INCREASED 67 0.0033
578 HEPATITIS 84 0.0033
579 SPINAL DISORDER 31 0.0033
580 PRODUCT AVAILABILITY ISSUE 74 0.0032
581 ADVERSE DRUG REACTION 291 0.0032
582 URINARY RETENTION 108 0.0032
583 DECREASED APPETITE 750 0.0032
584 HYPOTENSION 645 0.0032
585 ALANINE AMINOTRANSFERASE INCREASED 197 0.0032
586 BACK DISORDER 52 0.0032
587 HEPATIC FAILURE 96 0.0032
588 WHITE BLOOD CELL COUNT DECREASED 345 0.0032
589 PRODUCT PHYSICAL ISSUE 64 0.0032
590 LYMPHADENOPATHY 112 0.0032
591 FOOT DEFORMITY 35 0.0032
592 MUSCLE ATROPHY 40 0.0032
593 BRAIN NEOPLASM 29 0.0032
594 GASTRIC DISORDER 108 0.0031
595 PLATELET COUNT INCREASED 41 0.0031
596 FACE OEDEMA 53 0.0031
597 INABILITY TO AFFORD MEDICATION 31 0.0031
598 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 222 0.0031
599 DIZZINESS 1551 0.0031
600 PAIN 1906 0.0031
601 DIZZINESS POSTURAL 30 0.0031
602 MUSCLE SPASTICITY 38 0.0031
603 PRODUCT USE IN UNAPPROVED INDICATION 766 0.0031
604 BLOOD CREATININE INCREASED 201 0.0031
605 HYPERHIDROSIS 396 0.0031
606 LIVER INJURY 75 0.0031
607 RENAL FAILURE 405 0.0030
608 LUNG NEOPLASM MALIGNANT 125 0.0030
609 VIRAL INFECTION 101 0.0030
610 SKIN INFECTION 34 0.0030
611 SKIN LESION 83 0.0030
612 BONE DISORDER 55 0.0030
613 MEDICATION ERROR 167 0.0030
614 OSTEOARTHRITIS 127 0.0030
615 NEPHROLITHIASIS 137 0.0030
616 PERICARDIAL EFFUSION 69 0.0030
617 CYSTITIS 95 0.0030
618 CONSTIPATION 649 0.0030
619 TOOTH DISORDER 66 0.0030
620 BURSITIS 36 0.0030
621 MUSCLE TIGHTNESS 48 0.0030
622 RESPIRATORY TRACT CONGESTION 47 0.0030
623 PHARYNGITIS STREPTOCOCCAL 32 0.0030
624 BLOOD POTASSIUM INCREASED 48 0.0030
625 NECK PAIN 165 0.0029
626 DYSPEPSIA 290 0.0029
627 RECTAL HAEMORRHAGE 126 0.0029
628 EYELID OEDEMA 34 0.0029
629 HAEMATEMESIS 74 0.0029
630 CHOLESTASIS 56 0.0029
631 MUSCULOSKELETAL CHEST PAIN 45 0.0029
632 BRADYCARDIA 154 0.0029
633 MUSCULOSKELETAL STIFFNESS 254 0.0029
634 MOBILITY DECREASED 207 0.0029
635 ACCIDENTAL OVERDOSE 105 0.0029
636 BURNING SENSATION 201 0.0029
637 IMPAIRED HEALING 94 0.0029
638 HEART RATE INCREASED 283 0.0029
639 ARRHYTHMIA 135 0.0028
640 POLYNEUROPATHY 34 0.0028
641 VERTIGO 173 0.0028
642 NEURALGIA 69 0.0028
643 FEELING JITTERY 54 0.0028
644 ASTHENIA 1065 0.0028
645 ILEUS 35 0.0028
646 BRONCHITIS 208 0.0028
647 CORONARY ARTERY DISEASE 85 0.0028
648 TOOTH LOSS 58 0.0028
649 SUBDURAL HAEMATOMA 40 0.0028
650 PLEURAL EFFUSION 170 0.0028
651 SYNCOPE 279 0.0028
652 POISONING 35 0.0028
653 GINGIVAL BLEEDING 38 0.0028
654 PULMONARY THROMBOSIS 30 0.0027
655 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 132 0.0027
656 OESOPHAGITIS 30 0.0027
657 TRANSAMINASES INCREASED 61 0.0027
658 RASH MACULO-PAPULAR 61 0.0027
659 PRODUCT USE ISSUE 515 0.0027
660 SHOCK 63 0.0027
661 GASTRIC ULCER 52 0.0027
662 PHARYNGEAL OEDEMA 42 0.0027
663 PARALYSIS 39 0.0027
664 SKIN DISCOLOURATION 125 0.0027
665 PANCYTOPENIA 152 0.0027
666 CHROMATURIA 61 0.0027
667 CORONARY ARTERY OCCLUSION 37 0.0027
668 LOCAL SWELLING 47 0.0027
669 ACUTE KIDNEY INJURY 412 0.0027
670 HYPOKALAEMIA 124 0.0027
671 NAUSEA 2126 0.0027
672 LIVER DISORDER 119 0.0027
673 EYE DISORDER 88 0.0027
674 BLOOD CALCIUM DECREASED 30 0.0027
675 DRUG WITHDRAWAL SYNDROME 234 0.0027
676 PRODUCT TASTE ABNORMAL 36 0.0027
677 BLOOD ALKALINE PHOSPHATASE INCREASED 66 0.0027
678 CARDIAC ARREST 219 0.0026
679 RESPIRATORY ARREST 73 0.0026
680 ABDOMINAL PAIN 616 0.0026
681 BACK PAIN 615 0.0026
682 DRUG ADMINISTRATION ERROR 81 0.0026
683 MULTIPLE SCLEROSIS 126 0.0026
684 INSURANCE ISSUE 40 0.0026
685 HIP FRACTURE 84 0.0026
686 COLD SWEAT 46 0.0026
687 SEPSIS 290 0.0026
688 HYPOAESTHESIA 389 0.0026
689 SPINAL OPERATION 32 0.0026
690 TOOTHACHE 47 0.0026
691 HEADACHE 1623 0.0026
692 RESPIRATORY FAILURE 188 0.0026
693 CAESAREAN SECTION 30 0.0026
694 MUSCULOSKELETAL DISORDER 49 0.0026
695 ROTATOR CUFF SYNDROME 33 0.0026
696 MULTIPLE FRACTURES 42 0.0026
697 PRESCRIBED UNDERDOSE 51 0.0026
698 FATIGUE 1984 0.0025
699 SEASONAL ALLERGY 36 0.0025
700 RESPIRATORY DISORDER 76 0.0025
701 GLYCOSYLATED HAEMOGLOBIN INCREASED 64 0.0025
702 ABDOMINAL PAIN UPPER 520 0.0025
703 RENAL INJURY 75 0.0025
704 ISCHAEMIC STROKE 45 0.0025
705 C-REACTIVE PROTEIN INCREASED 91 0.0025
706 PERICARDITIS 42 0.0025
707 CYST 31 0.0025
708 ASTHMA 282 0.0025
709 HEAD DISCOMFORT 44 0.0025
710 HEART RATE IRREGULAR 56 0.0025
711 DEEP VEIN THROMBOSIS 161 0.0025
712 PRODUCT USE COMPLAINT 39 0.0025
713 CENTRAL NERVOUS SYSTEM LESION 34 0.0025
714 HAEMOGLOBIN DECREASED 254 0.0025
715 RASH GENERALISED 64 0.0025
716 CEREBROVASCULAR ACCIDENT 418 0.0025
717 BLOOD PRESSURE INCREASED 377 0.0025
718 BLOOD PRESSURE ABNORMAL 49 0.0025
719 TUBULOINTERSTITIAL NEPHRITIS 46 0.0025
720 PYREXIA 849 0.0025
721 ABSCESS 39 0.0024
722 INTESTINAL OBSTRUCTION 92 0.0024
723 GLAUCOMA 47 0.0024
724 LACTIC ACIDOSIS 79 0.0024
725 SWOLLEN TONGUE 76 0.0024
726 OFF LABEL USE 2128 0.0024
727 PARAESTHESIA 382 0.0024
728 PREGNANCY 48 0.0024
729 POST PROCEDURAL COMPLICATION 46 0.0024
730 HERNIA 46 0.0024
731 JAUNDICE 64 0.0024
732 VISUAL ACUITY REDUCED 79 0.0024
733 HYPOCALCAEMIA 45 0.0024
734 SINUS DISORDER 47 0.0024
735 IMPAIRED QUALITY OF LIFE 34 0.0024
736 DRUG INEFFECTIVE 3116 0.0024
737 ADVERSE EVENT 217 0.0024
738 CYANOSIS 37 0.0024
739 IMMUNE SYSTEM DISORDER 31 0.0023
740 TOOTH INFECTION 31 0.0023
741 CIRCULATORY COLLAPSE 40 0.0023
742 COAGULOPATHY 39 0.0023
743 PALPITATIONS 274 0.0023
744 PERIPHERAL COLDNESS 32 0.0023
745 MUSCULOSKELETAL DISCOMFORT 40 0.0023
746 OSTEOMYELITIS 42 0.0023
747 CARDIAC DISORDER 217 0.0023
748 THERAPY CESSATION 119 0.0023
749 CONJUNCTIVITIS 43 0.0023
750 MUSCLE SPASMS 425 0.0023
751 HAEMATOMA 60 0.0023
752 BLOOD COUNT ABNORMAL 35 0.0023
753 HEART RATE DECREASED 81 0.0023
754 PRODUCT DOSE OMISSION ISSUE 678 0.0023
755 SWELLING FACE 150 0.0023
756 MENORRHAGIA 45 0.0023
757 DIARRHOEA 1479 0.0023
758 FEELING HOT 140 0.0023
759 ABDOMINAL DISCOMFORT 383 0.0023
760 HYPERKALAEMIA 80 0.0023
761 VISUAL IMPAIRMENT 281 0.0023
762 LYMPHOCYTE COUNT DECREASED 40 0.0023
763 ADVERSE REACTION 30 0.0023
764 PRODUCTIVE COUGH 108 0.0023
765 MULTIPLE SCLEROSIS RELAPSE 155 0.0023
766 DRUG RESISTANCE 58 0.0023
767 HAEMATURIA 77 0.0022
768 MALAISE 984 0.0022
769 KIDNEY INFECTION 44 0.0022
770 PULMONARY EMBOLISM 212 0.0022
771 RESPIRATORY TRACT INFECTION 58 0.0022
772 BLOOD PRESSURE DECREASED 147 0.0022
773 PROTEINURIA 42 0.0022
774 BLOOD TEST ABNORMAL 31 0.0022
775 OROPHARYNGEAL PAIN 204 0.0022
776 MULTI-ORGAN FAILURE 38 0.0022
777 TENDONITIS 34 0.0022
778 BLOOD POTASSIUM DECREASED 66 0.0022
779 GASTROINTESTINAL DISORDER 195 0.0022
780 DRUG INTOLERANCE 210 0.0022
781 JOINT STIFFNESS 57 0.0022
782 NIGHT SWEATS 70 0.0022
783 EXPOSURE DURING PREGNANCY 134 0.0022
784 FEELING COLD 60 0.0022
785 PRODUCT QUALITY ISSUE 292 0.0021
786 SURGERY 126 0.0021
787 THROAT TIGHTNESS 58 0.0021
788 HAEMATOCHEZIA 118 0.0021
789 LIMB DISCOMFORT 66 0.0021
790 CATARACT 127 0.0021
791 PRODUCT DOSE OMISSION 139 0.0021
792 PHOTOSENSITIVITY REACTION 35 0.0021
793 CARDIO-RESPIRATORY ARREST 88 0.0021
794 PULMONARY OEDEMA 94 0.0021
795 FLATULENCE 119 0.0021
796 PAIN IN EXTREMITY 618 0.0021
797 THERAPEUTIC RESPONSE DECREASED 127 0.0021
798 DIVERTICULITIS 58 0.0021
799 DRUG EFFECT LESS THAN EXPECTED 31 0.0021
800 HIP ARTHROPLASTY 32 0.0021
801 ABDOMINAL DISTENSION 217 0.0021
802 SINUSITIS 213 0.0021
803 RASH 905 0.0021
804 ABORTION SPONTANEOUS 83 0.0021
805 SCIATICA 33 0.0021
806 BLISTER 116 0.0021
807 CLOSTRIDIUM DIFFICILE INFECTION 45 0.0021
808 ANGINA PECTORIS 59 0.0021
809 PRESYNCOPE 50 0.0021
810 UNDERDOSE 150 0.0021
811 INFLUENZA 228 0.0020
812 DIALYSIS 29 0.0020
813 MUSCULOSKELETAL PAIN 107 0.0020
814 CEREBRAL HAEMORRHAGE 73 0.0020
815 GAMMA-GLUTAMYLTRANSFERASE INCREASED 45 0.0020
816 HYPERSENSITIVITY 375 0.0020
817 GENERAL PHYSICAL HEALTH DETERIORATION 233 0.0020
818 ORAL PAIN 45 0.0020
819 ANAEMIA 383 0.0020
820 SNEEZING 45 0.0020
821 BLOOD GLUCOSE ABNORMAL 37 0.0020
822 VENTRICULAR TACHYCARDIA 33 0.0020
823 SWELLING 187 0.0020
824 SPINAL FRACTURE 40 0.0020
825 HYPOAESTHESIA ORAL 30 0.0020
826 BLOOD GLUCOSE INCREASED 374 0.0020
827 BONE DENSITY DECREASED 62 0.0020
828 PAIN IN JAW 56 0.0020
829 SEPTIC SHOCK 86 0.0020
830 PRODUCT DISPENSING ERROR 43 0.0020
831 BLINDNESS 80 0.0020
832 BLOOD GLUCOSE DECREASED 94 0.0020
833 SYRINGE ISSUE 34 0.0019
834 COUGH 544 0.0019
835 EPISTAXIS 145 0.0019
836 NASAL CONGESTION 113 0.0019
837 SKIN DISORDER 64 0.0019
838 RENAL IMPAIRMENT 161 0.0019
839 BRAIN FOG 30 0.0019
840 INFECTION 277 0.0019
841 ATRIAL FIBRILLATION 186 0.0019
842 LOCALISED INFECTION 46 0.0019
843 FRACTURE 36 0.0019
844 MYALGIA 323 0.0019
845 CHILLS 222 0.0019
846 DISEASE RECURRENCE 90 0.0019
847 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 339 0.0019
848 DRUG-INDUCED LIVER INJURY 59 0.0019
849 PRODUCT ADMINISTRATION ERROR 38 0.0019
850 LUNG DISORDER 92 0.0019
851 BLOOD PRESSURE FLUCTUATION 45 0.0019
852 PELVIC PAIN 34 0.0019
853 DYSPNOEA 1057 0.0019
854 INTENTIONAL DOSE OMISSION 53 0.0019
855 CARDIAC FAILURE CONGESTIVE 149 0.0019
856 COLITIS 70 0.0018
857 BLOOD URINE PRESENT 35 0.0018
858 ARTHRITIS 145 0.0018
859 GOUT 33 0.0018
860 INFLUENZA LIKE ILLNESS 151 0.0018
861 INTENTIONAL PRODUCT MISUSE 160 0.0018
862 THERAPY NON-RESPONDER 82 0.0018
863 BACTERIAL INFECTION 34 0.0018
864 PERIPHERAL SWELLING 279 0.0018
865 TREATMENT FAILURE 150 0.0018
866 PRURITUS GENERALISED 39 0.0018
867 MOUTH ULCERATION 38 0.0018
868 COMPLETED SUICIDE 149 0.0018
869 MATERNAL EXPOSURE DURING PREGNANCY 159 0.0018
870 ABDOMINAL PAIN LOWER 45 0.0018
871 LABORATORY TEST ABNORMAL 52 0.0018
872 HEPATIC CIRRHOSIS 33 0.0018
873 MYOCARDIAL INFARCTION 306 0.0018
874 THROMBOSIS 141 0.0018
875 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 354 0.0017
876 HYPOACUSIS 74 0.0017
877 CHEST DISCOMFORT 174 0.0017
878 ARTHROPATHY 94 0.0017
879 RASH MACULAR 59 0.0017
880 CONTRAINDICATED PRODUCT ADMINISTERED 51 0.0017
881 FUNGAL INFECTION 56 0.0017
882 ILLNESS 172 0.0017
883 MULTIPLE ORGAN DYSFUNCTION SYNDROME 47 0.0017
884 RHINORRHOEA 107 0.0017
885 LIVER FUNCTION TEST INCREASED 35 0.0016
886 SKIN ULCER 42 0.0016
887 INCORRECT DOSE ADMINISTERED 370 0.0016
888 THERAPY INTERRUPTED 115 0.0016
889 RASH PAPULAR 36 0.0016
890 PRODUCT PRESCRIBING ERROR 38 0.0016
891 DYSPNOEA EXERTIONAL 60 0.0016
892 OSTEONECROSIS 52 0.0016
893 STOMATITIS 96 0.0016
894 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 46 0.0016
895 FAECES DISCOLOURED 34 0.0016
896 INTENTIONAL PRODUCT USE ISSUE 137 0.0016
897 THERAPEUTIC PRODUCT EFFECT DECREASED 70 0.0016
898 EYE PAIN 88 0.0016
899 NASOPHARYNGITIS 287 0.0016
900 DYSPHONIA 91 0.0016
901 PULMONARY HYPERTENSION 32 0.0015
902 DYSGEUSIA 114 0.0015
903 EYE SWELLING 57 0.0015
904 LACRIMATION INCREASED 46 0.0015
905 PRODUCT DOSE OMISSION IN ERROR 43 0.0015
906 JOINT SWELLING 182 0.0015
907 VAGINAL HAEMORRHAGE 65 0.0015
908 DEPENDENCE 82 0.0015
909 FLUID RETENTION 76 0.0015
910 INFLAMMATION 77 0.0015
911 URTICARIA 248 0.0015
912 RASH PRURITIC 80 0.0015
913 ANAPHYLACTIC SHOCK 38 0.0015
914 ARTHRALGIA 608 0.0015
915 INCORRECT DRUG ADMINISTRATION DURATION 41 0.0015
916 THERAPEUTIC RESPONSE SHORTENED 48 0.0014
917 HAEMORRHAGE 151 0.0014
918 EXPIRED PRODUCT ADMINISTERED 48 0.0014
919 DRUG DEPENDENCE 228 0.0014
920 FLUSHING 144 0.0014
921 MELAENA 31 0.0014
922 NEEDLE ISSUE 41 0.0014
923 DRUG ABUSE 117 0.0014
924 BONE PAIN 82 0.0014
925 HOT FLUSH 105 0.0014
926 MENSTRUATION IRREGULAR 37 0.0014
927 RASH ERYTHEMATOUS 66 0.0014
928 INJECTION SITE MASS 51 0.0014
929 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 98 0.0014
930 DRY EYE 68 0.0014
931 ACUTE MYOCARDIAL INFARCTION 40 0.0014
932 DISCOMFORT 82 0.0013
933 GASTROINTESTINAL HAEMORRHAGE 109 0.0013
934 CARDIOVASCULAR DISORDER 33 0.0013
935 GLOSSODYNIA 29 0.0013
936 PRURITUS 491 0.0013
937 COVID-19 223 0.0013
938 ACNE 96 0.0013
939 LIP SWELLING 42 0.0013
940 HAEMOPTYSIS 35 0.0013
941 HEPATIC FUNCTION ABNORMAL 46 0.0012
942 CEREBRAL INFARCTION 30 0.0012
943 FEMUR FRACTURE 38 0.0012
944 DRUG EFFECT INCOMPLETE 44 0.0012
945 EXTRA DOSE ADMINISTERED 49 0.0012
946 COLITIS ULCERATIVE 54 0.0012
947 PREMATURE BABY 36 0.0012
948 ERYTHEMA 245 0.0012
949 OCULAR HYPERAEMIA 56 0.0012
950 LOWER RESPIRATORY TRACT INFECTION 53 0.0012
951 PROCEDURAL PAIN 32 0.0012
952 FREQUENT BOWEL MOVEMENTS 31 0.0011
953 THROAT IRRITATION 51 0.0011
954 SYSTEMIC LUPUS ERYTHEMATOSUS 40 0.0011
955 SKIN EXFOLIATION 95 0.0011
956 INJECTION SITE REACTION 75 0.0011
957 ASCITES 32 0.0011
958 PSORIATIC ARTHROPATHY 44 0.0011
959 ECZEMA 55 0.0010
960 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 35 0.0010
961 DEVICE BREAKAGE 41 0.0010
962 INCORRECT ROUTE OF DRUG ADMINISTRATION 36 0.0010
963 ANAPHYLACTIC REACTION 55 0.0010
964 PRODUCT ADHESION ISSUE 35 0.0010
965 DEATH 842 0.0010
966 HERPES ZOSTER 55 0.0010
967 DEVICE MALFUNCTION 63 0.0009
968 INJECTION SITE PAIN 272 0.0009
969 NEOPLASM MALIGNANT 59 0.0009
970 DEVICE DISLOCATION 38 0.0009
971 CARDIAC FAILURE 70 0.0009
972 DRY SKIN 116 0.0009
973 EYE PRURITUS 29 0.0009
974 ANGIOEDEMA 38 0.0009
975 PSORIASIS 110 0.0008
976 DEVICE LEAKAGE 36 0.0008
977 INJECTION SITE HAEMORRHAGE 65 0.0008
978 SKIN BURNING SENSATION 58 0.0008
979 INJECTION SITE SWELLING 60 0.0008
980 DISEASE PROGRESSION 91 0.0008
981 INJECTION SITE ERYTHEMA 94 0.0008
982 NO ADVERSE EVENT 135 0.0007
983 EYE IRRITATION 42 0.0007
984 FEBRILE NEUTROPENIA 47 0.0007
985 INJECTION SITE BRUISING 52 0.0007
986 BREAST CANCER 56 0.0006
987 INJECTION SITE PRURITUS 40 0.0006
988 INFUSION RELATED REACTION 38 0.0006
989 DEVICE ISSUE 50 0.0006
990 RHEUMATOID ARTHRITIS 63 0.0006
991 ACCIDENTAL EXPOSURE TO PRODUCT 52 0.0005
992 PRODUCT STORAGE ERROR 38 0.0004